department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Azelex · pharmadog

pharmadog
drugs
Azelex

drug

patient view →

azelaic acid

Marketedupdated 2mo ago

by Almirall SA

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Azelex

generic

azelaic acid

indication

Acne Vulgaris

phase

marketed

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Patent cliff

source: FDA Orange Book

first barrier falls

Sep 18, 2027

~1.2 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (4)

Feb 28, 2029method-of-use (U-1796)US 92112592.6y
Dec 8, 2027formulationUS 92657251.4y
Oct 18, 2027formulationUS 101178121.3y
Sep 18, 2027formulationUS 77000761.2y

Data sources

ClinicalTrials.gov

last refreshed 30m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 3

companyGlenmark Pharmaceuticals Ltd3 co-mentions · 1 sources
tagRecall1 co-mentions · 1 sources
drugFinacea1 co-mentions · 1 sources

Trials studying azelaic acid

phase1To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gelcompletedn=1,000
phase3Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acnecompletedn=879
phase2A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitiscompletedn=48
phase3Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosaceacompletedn=961
phase1Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosaceacompletedn=21
phase2A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Facecompletedn=48
phase4A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Dailycompletedn=98